Boehringer’s Spiolto Respimat COPD therapy approved in European countries

Boehringer Ingelheim Spiolto Respimat (tiotropium / olodaterol) once-daily maintenance treatment has received regulatory authority approvals in first European countries, to relieve symptoms in adult patients with chronic obstructive pulmonary disease…
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news